首頁 > 市場調查報告書 > 醫療設備

齒科設備

市場調查報告書

商品編碼

1665266

電切鏡設備市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

Resectoscope Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2024年12月18日 | 出版商:

Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球電切鏡設備市場價值為 4.022 億美元，預計 2025 年至 2034 年期間將以 5.7% 的強勁複合年成長率成長。外科技術和技巧的不斷進步進一步推動了全球醫療機構採用電切鏡設備。

根據類型，市場分為單極、雙極和混合電切鏡。單極電切鏡預計將實現顯著成長，預計複合年成長率為 5.5%，到 2034 年市場價值將達到 3.273 億美元。與雙極系統相比，它們的經濟實惠使其成為已開發地區和新興地區醫療保健提供者的有吸引力的選擇，確保了它們在未來幾年內持續佔據市場主導地位。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	4.022億美元
預測值	6.944 億美元
複合年成長率	5.7%

市場還根據最終用途進行細分，包括醫院、診所、門診手術中心和其他醫療保健提供者。 2024 年，醫院憑藉其先進的手術基礎設施和尖端成像技術的整合，佔據了 45.6% 的市場佔有率。泌尿科醫生和婦科醫生等專業人員的存在確保了手術過程的精確性和安全性，鞏固了醫院作為電切鏡設備應用的首選地位。他們處理複雜和微創手術的能力進一步增強了他們在市場上的地位。

在美國，2024 年電切鏡設備市場價值為 1.487 億美元，預計到 2034 年複合年成長率為 4.9%。此外，醫療支出增加、老齡人口成長以及微創手術需求增加等因素也推動了美國市場的持續成長

產業生態系統分析
產業衝擊力
- 成長動力
  - 泌尿科和婦科疾病盛行率上升
  - 技術進步
  - 轉向微創手術
- 產業陷阱與挑戰
  - 先進設備成本高昂
成長潛力分析
監管格局
報銷場景
技術格局
差距分析
波特的分析
PESTEL 分析
未來市場趨勢

第4章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
策略儀表板

第 5 章：市場估計與預測：按類型，2021 年至 2034 年

主要趨勢
單極電切鏡
雙極電切鏡
混合電切鏡

第 6 章：市場估計與預測：按應用，2021 年至 2034 年

主要趨勢
泌尿科
婦科
一般外科
其他應用

第 7 章：市場估計與預測：依最終用途，2021 年至 2034 年

主要趨勢
醫院
診所
門診手術中心
其他最終用戶

第 8 章：市場估計與預測：按地區，2021 年至 2034 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第9章：公司簡介

Advin Urology
bissinger
ESC Medicams
ENDOMED SYSTEMS
JDmeditech
KARL STORZ
LEPU MEDICAL
OLYMPUS
Orion Medical
Richard Wolf
Stryker
TONTARRA

簡介目錄

Product Code: 12746

The Global Resectoscope Devices Market, valued at USD 402.2 million in 2024, is anticipated to grow at a robust CAGR of 5.7% between 2025 and 2034. This growth is driven by the rising prevalence of urological and gynecological conditions and an increasing preference for minimally invasive surgical procedures. Continued advancements in surgical technologies and techniques are further propelling the adoption of resectoscope devices in healthcare facilities worldwide.

By type, the market is segmented into monopolar, bipolar, and hybrid resectoscopes. Monopolar resectoscopes are expected to see significant growth, with a projected CAGR of 5.5%, reaching a market value of USD 327.3 million by 2034. These devices are widely favored for their efficiency and cost-effectiveness, particularly in transurethral and gynecological surgeries. Their affordability compared to bipolar systems makes them an attractive option for healthcare providers in both developed and emerging regions, ensuring their sustained market dominance over the coming years.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$402.2 Million
Forecast Value	$694.4 Million
CAGR	5.7%

The market is also segmented by end use, including hospitals, clinics, ambulatory surgical centers, and other healthcare providers. Hospitals accounted for a leading 45.6% share of the market in 2024, bolstered by their advanced surgical infrastructure and integration of cutting-edge imaging technologies. The presence of specialized professionals such as urologists and gynecologists ensures precision and safety during procedures, solidifying hospitals as the top choice for resectoscope device applications. Their ability to handle both complex and minimally invasive surgeries further enhances their position in the market.

In the United States, the resectoscope devices market was valued at USD 148.7 million in 2024, with a projected CAGR of 4.9% through 2034. The country's well-established healthcare infrastructure, widespread adoption of advanced surgical equipment, and the presence of key market players are driving its dominance. Additionally, factors such as increased healthcare spending, a growing elderly population, and rising demand for minimally invasive surgeries contribute to sustained market growth in the U.S.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of urological and gynecological disorders
  - 3.2.1.2 Technological advancements
  - 3.2.1.3 Shift towards minimally invasive procedures
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High costs of advanced devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technology landscape
3.7 Gap analysis
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

5.1 Key trends
5.2 Monopolar resectoscopes
5.3 Bipolar resectoscopes
5.4 Hybrid resectoscopes

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

6.1 Key trends
6.2 Urology
6.3 Gynecology
6.4 General surgery
6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Ambulatory surgical centers
7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE